AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
3,8-diazabicyclo[3.2.1]octan-2-one peptide mimetics: Synthesis of a conformationally restricted inhibitor of farnesyltransferase
Authors: Dinsmore, CJ Bergman, JM Bogusky, MJ Culterson, JC Hamilton, KA Graham, SL
Citation: Cj. Dinsmore et al., 3,8-diazabicyclo[3.2.1]octan-2-one peptide mimetics: Synthesis of a conformationally restricted inhibitor of farnesyltransferase, ORG LETT, 3(6), 2001, pp. 865-868
Central corneal thickness, tonometry, and ocular dimensions in glaucoma and ocular hypertension
Authors: Singh, RP Goldberg, I Graham, SL Sharma, A Mohsin, M
Citation: Rp. Singh et al., Central corneal thickness, tonometry, and ocular dimensions in glaucoma and ocular hypertension, J GLAUCOMA, 10(3), 2001, pp. 206-210
2-Arylindole-3-acetamides: FPP-competitive inhibitors of farnesyl protein transferase
Authors: Trotter, BW Quigley, AG Lumma, WC Sisko, JT Walsh, ES Hamann, CS Robinson, RG Bhimnathwala, H Kolodin, DG Zheng, W Buser, CA Huber, HE Lobell, RB Kohl, NE Williams, TM Graham, SL Dinsmore, CJ
Citation: Bw. Trotter et al., 2-Arylindole-3-acetamides: FPP-competitive inhibitors of farnesyl protein transferase, BIOORG MED, 11(7), 2001, pp. 865-869
Oxo-piperazine derivatives of N-arylpiperazinones as inhibitors of farnesyltransferase
Authors: Dinsmore, CJ Bergman, JM Wei, DD Zartman, CB Davide, JP Greenberg, IB Liu, DM O'Neill, TJ Gibbs, JB Koblan, KS Kohl, NE Lobell, RB Chen, IW McLoughlin, DA Olah, TV Graham, SL Hartman, GD Williams, TM
Citation: Cj. Dinsmore et al., Oxo-piperazine derivatives of N-arylpiperazinones as inhibitors of farnesyltransferase, BIOORG MED, 11(4), 2001, pp. 537-540
Evaluation of amino acid-based linkers in potent macrocyclic inhibitors offarnesyl-protein transferase
Authors: Beshore, DC Bell, IM Dinsmore, CJ Homnick, CF Culberson, JC Robinson, RG Fernandes, C Walsh, ES Abrams, MT Bhimnathwala, HG Davide, JP Ellis-Hutchings, MS Huber, HA Koblan, KS Buser, CA Kohl, NE Lobell, RB Chen, IW McLoughlin, DA Olah, TV Graham, SL Hartman, GD Williams, TM
Citation: Dc. Beshore et al., Evaluation of amino acid-based linkers in potent macrocyclic inhibitors offarnesyl-protein transferase, BIOORG MED, 11(14), 2001, pp. 1817-1821
Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I
Authors: Bergman, JM Abrams, MT Davide, JP Greenberg, IB Robinson, RG Buser, CA Huber, HE Koblan, KS Kohl, NE Lobell, RB Graham, SL Hartman, GD Williams, TM Dinsmore, CJ
Citation: Jm. Bergman et al., Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I, BIOORG MED, 11(11), 2001, pp. 1411-1415
Diaryl ether inhibitors of farnesyl-protein transferase
Authors: MacTough, SC DeSolms, SJ Shaw, AW Abrams, MT Ciccarone, TR Davide, JP Hamilton, KA Hutchinson, JH Koblan, KS Kohl, NE Lobell, RB Robinson, RG Graham, SL
Citation: Sc. Mactough et al., Diaryl ether inhibitors of farnesyl-protein transferase, BIOORG MED, 11(10), 2001, pp. 1257-1260
Electroencephalogram-based scaling of multifocal visual evoked potentials:Effect on intersubject amplitude variability
Authors: Klistorner, AI Graham, SL
Citation: Ai. Klistorner et Sl. Graham, Electroencephalogram-based scaling of multifocal visual evoked potentials:Effect on intersubject amplitude variability, INV OPHTH V, 42(9), 2001, pp. 2145-2152
Design and biological activity of (S)-4-(5-{[1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl}imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potency
Authors: Bell, IM Gallicchio, SN Abrams, M Beshore, DC Buser, CA Culberson, JC Davide, J Ellis-Hutchings, M Fernandes, C Gibbs, JB Graham, SL Hartman, GD Heimbrook, DC Homnick, CF Huff, JR Kassahun, K Koblan, KS Kohl, NE Lobell, RB Lynch, JJ Miller, PA Omer, CA Rodrigues, AD Walsh, ES Williams, TM
Citation: Im. Bell et al., Design and biological activity of (S)-4-(5-{[1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl}imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potency, J MED CHEM, 44(18), 2001, pp. 2933-2949
Anions modulate the potency of geranylgeranyl-protein transferase I inhibitors
Authors: Huber, HE Robinson, RG Watkins, A Nahas, DD Abrams, MT Buser, CA Lobell, RB Patrick, D Anthony, NJ Dinsmore, CJ Graham, SL Hartman, GD Lumma, WC Williams, TM Heimbrook, DC
Citation: He. Huber et al., Anions modulate the potency of geranylgeranyl-protein transferase I inhibitors, J BIOL CHEM, 276(27), 2001, pp. 24457-24465
Conformational restriction of flexible ligands guided by the transferred NOE experiment: Potent macrocyclic inhibitors of farnesyltransferase
Authors: Dinsmore, CJ Bogusky, MJ Culberson, JC Bergman, JM Homnick, CF Zartman, CB Mosser, SD Schaber, MD Robinson, RG Koblan, KS Huber, HE Graham, SL Hartman, GD Huff, JR Williams, TM
Citation: Cj. Dinsmore et al., Conformational restriction of flexible ligands guided by the transferred NOE experiment: Potent macrocyclic inhibitors of farnesyltransferase, J AM CHEM S, 123(9), 2001, pp. 2107-2108
Antitumor efficacy of a farnesyltransferase inhibitor in transgenic mice
Authors: Gibbs, JB Graham, SL Hartman, GD Koblan, KS Kohl, NE Omer, C Pellicier, A Windle, J Oliff, A
Citation: Jb. Gibbs et al., Antitumor efficacy of a farnesyltransferase inhibitor in transgenic mice, CANC DRUG, 8, 2001, pp. 65-70
Objective VEP perimetry in glaucoma: Asymmetry analysis to identify early deficits
Authors: Graham, SL Klistorner, AI Grigg, JR Billson, FA
Citation: Sl. Graham et al., Objective VEP perimetry in glaucoma: Asymmetry analysis to identify early deficits, J GLAUCOMA, 9(1), 2000, pp. 10-19
Comparison of the Humphrey Swedish interactive thresholding algorithm (SITA) and full threshold strategies
Authors: Sharma, AK Goldberg, I Graham, SL Mohsin, M
Citation: Ak. Sharma et al., Comparison of the Humphrey Swedish interactive thresholding algorithm (SITA) and full threshold strategies, J GLAUCOMA, 9(1), 2000, pp. 20-27
Objective perimetry in glaucoma
Authors: Klistorner, A Graham, SL
Citation: A. Klistorner et Sl. Graham, Objective perimetry in glaucoma, OPHTHALMOL, 107(12), 2000, pp. 2283-2299
Early magnocellular loss in glaucoma demonstrated using the pseudorandomlystimulated flash visual evoked potential
Authors: Klistorner, AI Graham, SL
Citation: Ai. Klistorner et Sl. Graham, Early magnocellular loss in glaucoma demonstrated using the pseudorandomlystimulated flash visual evoked potential, J GLAUCOMA, 8(2), 1999, pp. 140-148
Imidazole-containing diarylether and diarylsulfone inhibitors of farnesyl-protein transferase
Authors: Dinsmore, CJ Williams, TM O'Neill, TJ Liu, DM Rands, E Culberson, JC Lobell, RB Koblan, KS Kohl, NE Gibbs, JB Oliff, AI Graham, SL Hartman, GD
Citation: Cj. Dinsmore et al., Imidazole-containing diarylether and diarylsulfone inhibitors of farnesyl-protein transferase, BIOORG MED, 9(23), 1999, pp. 3301-3306
Non-thiol 3-aminomethylbenzamide inhibitors of farnesyl-protein transferase
Authors: Ciccarone, TM MacTough, SC Williams, TM Dinsmore, CJ O'Neill, TJ Shah, D Culberson, JC Koblan, KS Kohl, NE Gibbs, JB Oliff, AI Graham, SL Hartman, GD
Citation: Tm. Ciccarone et al., Non-thiol 3-aminomethylbenzamide inhibitors of farnesyl-protein transferase, BIOORG MED, 9(14), 1999, pp. 1991-1996
Performance evaluation of a permeable reactive barrier for remediation of dissolved chlorinated solvents in groundwater
Authors: Vogan, JL Focht, RM Clark, DK Graham, SL
Citation: Jl. Vogan et al., Performance evaluation of a permeable reactive barrier for remediation of dissolved chlorinated solvents in groundwater, J HAZARD M, 68(1-2), 1999, pp. 97-108
Nocturnal hypotension: Role in glaucoma progression
Authors: Graham, SL Drance, SM
Citation: Sl. Graham et Sm. Drance, Nocturnal hypotension: Role in glaucoma progression, SURV OPHTHA, 43, 1999, pp. S10-S16
Objective perimetry in glaucoma: Recent advances with multifocal stimuli
Authors: Graham, SL Klistorner, A Grigg, JR Billson, FA
Citation: Sl. Graham et al., Objective perimetry in glaucoma: Recent advances with multifocal stimuli, SURV OPHTHA, 43, 1999, pp. S199-S209
N-arylpiperazinone inhibitors of farnesyltransferase: Discovery and biological activity
Authors: Williams, TM Bergman, JM Brashear, K Breslin, MJ Dinsmore, CJ Hutchinson, JH MacTough, SC Stump, CA Wei, DD Zartman, CB Bogusky, MJ Culberson, JC Buser-Doepner, C Davide, J Greenberg, IB Hamilton, KA Koblan, KS Kohl, NE Liu, DM Lobell, RB Mosser, SD O'Neill, TJ Rands, E Schaber, MD Wilson, F Senderak, E Motzel, SL Gibbs, JB Graham, SL Heimbrook, DC Hartman, GD Oliff, AI Huff, JR
Citation: Tm. Williams et al., N-arylpiperazinone inhibitors of farnesyltransferase: Discovery and biological activity, J MED CHEM, 42(19), 1999, pp. 3779-3784
Design and in vivo analysis of potent non-thiol inhibitors of farnesyl protein transferase
Authors: Anthony, NJ Gomez, RP Schaber, MD Mosser, SD Hamilton, KA O'Neil, TJ Koblan, KS Graham, SL Hartman, GD Shah, D Rands, E Kohl, NE Gibbs, JB Oliff, AI
Citation: Nj. Anthony et al., Design and in vivo analysis of potent non-thiol inhibitors of farnesyl protein transferase, J MED CHEM, 42(17), 1999, pp. 3356-3368
History of private life
Authors: Graham, R Graham, SL
Citation: R. Graham et Sl. Graham, History of private life, J LAT AM ST, 31, 1999, pp. 191-194
Daily living and private life in the empire
Authors: Graham, R Graham, SL
Citation: R. Graham et Sl. Graham, Daily living and private life in the empire, J LAT AM ST, 31, 1999, pp. 191-194
Risultati: 1-25 | 26-28